Small-company stocks are heating up, and it isn’t just because investors are growing weary of artificial intelligence.

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...

Risk-loving investors, who give precedence to capital appreciation along with dividend payouts, may consider small-cap blend mutual funds to derive healthy returns. These funds focus on realizing an ...

Vanguard Small-Cap ETF VB offers a well-diversified, low-turnover portfolio that is representative of the US small-cap market. These features, coupled with a minuscule fee, make it one of the best ...

Fri, January 9, 2026 at 3:15 PM UTC Small-cap stocks are finally having their moment. After years of mega-cap tech dominance, the Russell 2000 is surging in the first week of 2026, outpacing both the ...

IWN has delivered a stronger one-year return but carries a higher expense ratio than VBR. VBR is more concentrated in industrials, while IWN leans more heavily into financial services and real estate.

The small‑cap tech sector — broadly companies often defined in the U.S. as those with market capitalizations under roughly $200 million to $2 billion — currently occupies a precarious yet potentially ...

In this article, we will look at the 10 Overlooked Small Cap Stocks to Buy Now. On January 2, Royce Investment released its Small-Cap Recap Q4 2025 report, highlighting that the last quarter of 2025 ...

Thanks to inflation, $100 doesn't sound like much these days, but there's another way for investors to look at that amount. Consider it as a seed to be planted and, when tended to, one that will grow ...

Small cap mutual funds that invest in the stocks of very small companies have given among the worst performers in 2025 with a negative average return of 5%. In December 2025, the small cap funds again ...

For more than a decade, large caps have consistently outperformed small caps. The early performance of equities in 2026 demonstrates why small caps should be held as part of a diversified portfolio ...

Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry's major ...